Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-21

FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approves Hospira's supplemental application for ketorolac tromethamine, a generic NSAID. The approval pertains to a supplemental change to the product's app…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac tromethamine (Ketorolac tromethamine)

Snippet

SUPPL AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)